bis(4-(3-tert-butylpyrazol-1-id-5-yl)quinazoline);tris(4-(5-methylpyrazol-2-id-3-yl)quinazoline);tetrakis(platinum(2+));bis(4-(4,5,6,7-tetrahydroindazol-2-id-3-yl)quinazoline);4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline

C108H89F3N32Pt4 — CID 158165180

About bis(4-(3-tert-butylpyrazol-1-id-5-yl)quinazoline);tris(4-(5-methylpyrazol-2-id-3-yl)quinazoline);tetrakis(platinum(2+));bis(4-(4,5,6,7-tetrahydroindazol-2-id-3-yl)quinazoline);4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline

bis(4-(3-tert-butylpyrazol-1-id-5-yl)quinazoline);tris(4-(5-methylpyrazol-2-id-3-yl)quinazoline);tetrakis(platinum(2+));bis(4-(4,5,6,7-tetrahydroindazol-2-id-3-yl)quinazoline);4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline (PubChem CID 158165180) has the molecular formula C108H89F3N32Pt4 and a molecular weight of 2672.43 g/mol. Its IUPAC name is bis(4-(3-tert-butylpyrazol-1-id-5-yl)quinazoline);tris(4-(5-methylpyrazol-2-id-3-yl)quinazoline);tetrakis(platinum(2+));bis(4-(4,5,6,7-tetrahydroindazol-2-id-3-yl)quinazoline);4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline.

Molecular Properties

• Compound Name: bis(4-(3-tert-butylpyrazol-1-id-5-yl)quinazoline);tris(4-(5-methylpyrazol-2-id-3-yl)quinazoline);tetrakis(platinum(2+));bis(4-(4,5,6,7-tetrahydroindazol-2-id-3-yl)quinazoline);4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline
• PubChem CID: 158165180
• Molecular Formula: C108H89F3N32Pt4
• Molecular Weight: 2672.43 g/mol
• Exact Mass: 2670.65
• IUPAC Name: bis(4-(3-tert-butylpyrazol-1-id-5-yl)quinazoline);tris(4-(5-methylpyrazol-2-id-3-yl)quinazoline);tetrakis(platinum(2+));bis(4-(4,5,6,7-tetrahydroindazol-2-id-3-yl)quinazoline);4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline
• SMILES: CC(C)(C)c1cc(-c2ncnc3ccccc23)[n-]n1.CC(C)(C)c1cc(-c2ncnc3ccccc23)[n-]n1.Cc1cc(-c2ncnc3ccccc23)[n-]n1.Cc1cc(-c2ncnc3ccccc23)[n-]n1.Cc1cc(-c2ncnc3ccccc23)[n-]n1.FC(F)(F)c1cc(-c2ncnc3ccccc23)[n-]n1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].c1ccc2c(-c3[n-]nc4c3CCCC4)ncnc2c1.c1ccc2c(-c3[n-]nc4c3CCCC4)ncnc2c1
• InChI: InChI=1S/2C15H13N4.2C15H15N4.C12H6F3N4.3C12H9N4.4Pt/c2*1-3-7-12-10(5-1)14(17-9-16-12)15-11-6-2-4-8-13(11)18-19-15;2*1-15(2,3)13-8-12(18-19-13)14-10-6-4-5-7-11(10)16-9-17-14;13-12(14,15)10-5-9(18-19-10)11-7-3-1-2-4-8(7)16-6-17-11;3*1-8-6-11(16-15-8)12-9-4-2-3-5-10(9)13-7-14-12;;;;/h2*1,3,5,7,9H,2,4,6,8H2;2*4-9H,1-3H3;1-6H;3*2-7H,1H3;;;;/q8*-1;4*+2
• InChIKey: FWTFTTLWHJMYOG-UHFFFAOYSA-N
• XLogP: 19.48
• TPSA: 422.16 Ų
• H-Bond Acceptors: 24
• Rotatable Bonds: 8
• Heavy Atoms: 147
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2672.43
LogP ≤ 5	19.48
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	24

Frequently Asked Questions

What is the IUPAC name of bis(4-(3-tert-butylpyrazol-1-id-5-yl)quinazoline);tris(4-(5-methylpyrazol-2-id-3-yl)quinazoline);tetrakis(platinum(2+));bis(4-(4,5,6,7-tetrahydroindazol-2-id-3-yl)quinazoline);4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline?

The IUPAC name of bis(4-(3-tert-butylpyrazol-1-id-5-yl)quinazoline);tris(4-(5-methylpyrazol-2-id-3-yl)quinazoline);tetrakis(platinum(2+));bis(4-(4,5,6,7-tetrahydroindazol-2-id-3-yl)quinazoline);4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline (CID 158165180) is bis(4-(3-tert-butylpyrazol-1-id-5-yl)quinazoline);tris(4-(5-methylpyrazol-2-id-3-yl)quinazoline);tetrakis(platinum(2+));bis(4-(4,5,6,7-tetrahydroindazol-2-id-3-yl)quinazoline);4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline.

What is the SMILES notation for bis(4-(3-tert-butylpyrazol-1-id-5-yl)quinazoline);tris(4-(5-methylpyrazol-2-id-3-yl)quinazoline);tetrakis(platinum(2+));bis(4-(4,5,6,7-tetrahydroindazol-2-id-3-yl)quinazoline);4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline?

The canonical SMILES for bis(4-(3-tert-butylpyrazol-1-id-5-yl)quinazoline);tris(4-(5-methylpyrazol-2-id-3-yl)quinazoline);tetrakis(platinum(2+));bis(4-(4,5,6,7-tetrahydroindazol-2-id-3-yl)quinazoline);4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline is CC(C)(C)c1cc(-c2ncnc3ccccc23)[n-]n1.CC(C)(C)c1cc(-c2ncnc3ccccc23)[n-]n1.Cc1cc(-c2ncnc3ccccc23)[n-]n1.Cc1cc(-c2ncnc3ccccc23)[n-]n1.Cc1cc(-c2ncnc3ccccc23)[n-]n1.FC(F)(F)c1cc(-c2ncnc3ccccc23)[n-]n1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].c1ccc2c(-c3[n-]nc4c3CCCC4)ncnc2c1.c1ccc2c(-c3[n-]nc4c3CCCC4)ncnc2c1.

What is the InChIKey of bis(4-(3-tert-butylpyrazol-1-id-5-yl)quinazoline);tris(4-(5-methylpyrazol-2-id-3-yl)quinazoline);tetrakis(platinum(2+));bis(4-(4,5,6,7-tetrahydroindazol-2-id-3-yl)quinazoline);4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline?

The InChIKey is FWTFTTLWHJMYOG-UHFFFAOYSA-N. The full InChI is InChI=1S/2C15H13N4.2C15H15N4.C12H6F3N4.3C12H9N4.4Pt/c2*1-3-7-12-10(5-1)14(17-9-16-12)15-11-6-2-4-8-13(11)18-19-15;2*1-15(2,3)13-8-12(18-19-13)14-10-6-4-5-7-11(10)16-9-17-14;13-12(14,15)10-5-9(18-19-10)11-7-3-1-2-4-8(7)16-6-17-11;3*1-8-6-11(16-15-8)12-9-4-2-3-5-10(9)13-7-14-12;;;;/h2*1,3,5,7,9H,2,4,6,8H2;2*4-9H,1-3H3;1-6H;3*2-7H,1H3;;;;/q8*-1;4*+2.

What are the key properties of bis(4-(3-tert-butylpyrazol-1-id-5-yl)quinazoline);tris(4-(5-methylpyrazol-2-id-3-yl)quinazoline);tetrakis(platinum(2+));bis(4-(4,5,6,7-tetrahydroindazol-2-id-3-yl)quinazoline);4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline?

bis(4-(3-tert-butylpyrazol-1-id-5-yl)quinazoline);tris(4-(5-methylpyrazol-2-id-3-yl)quinazoline);tetrakis(platinum(2+));bis(4-(4,5,6,7-tetrahydroindazol-2-id-3-yl)quinazoline);4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline has a molecular weight of 2672.43 g/mol, XLogP of 19.48, 8 rotatable bonds, 0 hydrogen bond donors, and 24 hydrogen bond acceptors.

Where does this data come from?

All data for bis(4-(3-tert-butylpyrazol-1-id-5-yl)quinazoline);tris(4-(5-methylpyrazol-2-id-3-yl)quinazoline);tetrakis(platinum(2+));bis(4-(4,5,6,7-tetrahydroindazol-2-id-3-yl)quinazoline);4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline is sourced from PubChem (CID 158165180), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).